Home/Filings/4/0001694665-21-000021
4//SEC Filing

Liu Xiaoli Jacqueline 4

Accession 0001694665-21-000021

CIK 0001694665other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 5:30 PM ET

Size

7.6 KB

Accession

0001694665-21-000021

Insider Transaction Report

Form 4
Period: 2021-01-27
Liu Xiaoli Jacqueline
Principal Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-01-27+24,00024,000 total
    Exercise: $16.65Exp: 2031-01-27Common Stock (24,000 underlying)
  • Award

    Restricted Stock Units

    2021-01-27+5,6805,680 total
    Exercise: $0.00Exp: 2031-01-27Common Stock (5,680 underlying)
Footnotes (2)
  • [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
  • [F2]These restricted stock units will vest in four substantially equal annual installments on the anniversary of the date of grant, subject to continued employment on such dates.

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1
  • filerCIK 0001805198

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:30 PM ET
Size
7.6 KB